Avanos Medical Stock Number Of Employees
| 8HH Stock | 17.50 0.60 3.55% |
Avanos Medical fundamentals help investors to digest information that contributes to Avanos Medical's financial success or failures. It also enables traders to predict the movement of Avanos Stock. The fundamental analysis module provides a way to measure Avanos Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avanos Medical stock.
Avanos |
Avanos Medical Company Number Of Employees Analysis
Avanos Medical's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Avanos Medical is currently employing 0.0 people. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Number Of Employees (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Avanos Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avanos Medical's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avanos Medical could also be used in its relative valuation, which is a method of valuing Avanos Medical by comparing valuation metrics of similar companies.Avanos Medical is currently under evaluation in number of employees category among its peers.
Avanos Fundamentals
| Current Valuation | 1.35 B | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 1.60 X | |||
| Revenue | 820 M | |||
| EBITDA | 122.9 M | |||
| Net Income | 50.5 M | |||
| Total Debt | 226.3 M | |||
| Cash Flow From Operations | 90.9 M | |||
| Market Capitalization | 1.26 B | |||
| Total Asset | 1.79 B | |||
| Z Score | 3.0 | |||
| Net Asset | 1.79 B |
About Avanos Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avanos Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avanos Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avanos Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.